Shiyi Yang

1.7k total citations · 1 hit paper
16 papers, 775 citations indexed

About

Shiyi Yang is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Shiyi Yang has authored 16 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Shiyi Yang's work include Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Shiyi Yang is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Shiyi Yang collaborates with scholars based in United States, Netherlands and Spain. Shiyi Yang's co-authors include Masanao Yajima, Joshua D. Campbell, Yusuke Koga, Zhe Wang, W. Evan Johnson, Sean Corbett, María‐Victoria Mateos, Jesús G. Berdeja, Paula Rodríguez‐Otero and Niels W.C.J. van de Donk and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Shiyi Yang

16 papers receiving 762 citations

Hit Papers

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antib... 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
    2022 350 citations Ajai Chari, Monique C. Minnema et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiyi Yang United States 9 377 369 281 159 145 16 775
Geneviève Fiol France 13 328 0.9× 489 1.3× 412 1.5× 489 3.1× 120 0.8× 16 1.1k
Björn Schneider Germany 22 242 0.6× 502 1.4× 295 1.0× 137 0.9× 72 0.5× 63 1.2k
Keegan Barry-Holson United States 8 403 1.1× 521 1.4× 463 1.6× 447 2.8× 72 0.5× 11 1.3k
Nadja Zaborsky Austria 18 336 0.9× 283 0.8× 102 0.4× 386 2.4× 53 0.4× 49 945
Francesco Lanza Italy 15 205 0.5× 292 0.8× 116 0.4× 159 1.0× 79 0.5× 31 809
Natalie Fadle Germany 16 114 0.3× 353 1.0× 94 0.3× 301 1.9× 89 0.6× 38 780
Mara Dottore Australia 18 380 1.0× 320 0.9× 149 0.5× 730 4.6× 139 1.0× 23 1.2k
Christopher A. Bristow United States 15 243 0.6× 586 1.6× 215 0.8× 93 0.6× 30 0.2× 30 995
Alexandra Schebesta Austria 12 236 0.6× 586 1.6× 200 0.7× 759 4.8× 41 0.3× 13 1.4k
AL Mui Canada 11 445 1.2× 430 1.2× 280 1.0× 592 3.7× 78 0.5× 13 1.2k

Countries citing papers authored by Shiyi Yang

Since Specialization
Citations

This map shows the geographic impact of Shiyi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyi Yang more than expected).

Fields of papers citing papers by Shiyi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyi Yang. The network helps show where Shiyi Yang may publish in the future.

Co-authorship network of co-authors of Shiyi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyi Yang. A scholar is included among the top collaborators of Shiyi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyi Yang. Shiyi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Wang, Zhe, Shiyi Yang, Yusuke Koga, et al.. (2022). Celda: a Bayesian model to perform co-clustering of genes into modules and cells into subpopulations using single-cell RNA-seq data. NAR Genomics and Bioinformatics. 4(3). lqac066–lqac066. 16 indexed citations
3.
4.
Zhang, Ping, Yonglei Zhang, Shiyi Yang, et al.. (2022). Functional analysis of TcCTL12 in innate immunity and development in Tribolium castaneum. International Journal of Biological Macromolecules. 206. 422–434. 9 indexed citations
5.
6.
Minnema, Monique C., Amrita Krishnan, Jesús G. Berdeja, et al.. (2022). Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from MonumenTAL-1.. Journal of Clinical Oncology. 40(16_suppl). 8015–8015. 16 indexed citations
7.
Chari, Ajai, Monique C. Minnema, Jesús G. Berdeja, et al.. (2022). Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. New England Journal of Medicine. 387(24). 2232–2244. 350 indexed citations breakdown →
8.
Chevalier, Aaron, Shiyi Yang, Tong Tong, et al.. (2021). The Mutational Signature Comprehensive Analysis Toolkit (musicatk) for the Discovery, Prediction, and Exploration of Mutational Signatures. Cancer Research. 81(23). 5813–5817. 13 indexed citations
9.
10.
Nahi, Hareth, Saad Z. Usmani, María‐Victoria Mateos, et al.. (2020). Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study.. Journal of Clinical Oncology. 38(15_suppl). 8537–8537. 1 indexed citations
11.
Yang, Shiyi, Sean Corbett, Yusuke Koga, et al.. (2020). Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome biology. 21(1). 57–57. 219 indexed citations
12.
Chari, Ajai, Hartmut Goldschmidt, Shiyi Yang, et al.. (2019). Subcutaneous Daratumumab Plus Carfilzomib and Dexamethasone (D-Kd) in Relapsed/Refractory Multiple Myeloma: An Open-label, Multicenter, Phase 2 Study (PLEIADES). Clinical Lymphoma Myeloma & Leukemia. 19(10). e144–e144. 2 indexed citations
13.
Dai, Jinran, et al.. (2017). Interspecific cross‐hybrids of Nicotiana tabacum L. cv. (gla.) S ‘K326’ with Nicotiana alata. Plant Breeding. 136(3). 427–435. 4 indexed citations
14.
Rule, Simon, Martin Dreyling, André Goy, et al.. (2017). Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open‐label studies. British Journal of Haematology. 179(3). 430–438. 90 indexed citations
15.
Li, Fei, Shiyi Yang, Linguo Zhao, Qi Li, & Jianjun Pei. (2012). SYNONYMOUS CONDON USAGE BIAS AND OVEREXPRESSION OF A SYNTHETIC xynB GENE FROM Aspergillus niger NL-1 IN Pichia pastoris. BioResources. 7(2). 8 indexed citations
16.
Yang, Shiyi, A. Joseph Brough, & Judith Bernstein. (1972). Tumors of the liver in early infancy: hepatoblastoma.. PubMed. 71(17). 539–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Fiol Breakdown of academic impact, for papers by Björn Schneider Breakdown of academic impact, for papers by Keegan Barry-Holson Breakdown of academic impact, for papers by Nadja Zaborsky Breakdown of academic impact, for papers by Francesco Lanza Breakdown of academic impact, for papers by Natalie Fadle Breakdown of academic impact, for papers by Mara Dottore Breakdown of academic impact, for papers by Christopher A. Bristow Breakdown of academic impact, for papers by Alexandra Schebesta Breakdown of academic impact, for papers by AL Mui
Rankless by CCL
2026